Superoxide formation and interaction with nitric oxide modulate systemic arterial pressure and renal function in salt-depleted dogs

Experimental Biology and Medicine

Volumn 231, Issue 3, 2006, Pages 269-276

  Dutta, Utpal K ^a   Lane, Jason ^a   Roberts II, L Jackson ^b   Majid, Dewan S A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Oxidative stress; Renal blood flow; Sodium restriction; Tempol

Indexed keywords

ANGIOTENSIN; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RENIN; SCAVENGER; SODIUM; SODIUM CHLORIDE; SUPEROXIDE; TEMPOL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG INFUSION; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; MALE; MOLECULAR INTERACTION; NONHUMAN; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; URINARY EXCRETION;

ANIMALIA; CANIS FAMILIARIS;

EID: 33644673174     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100305     Document Type: Article

References (45)

1. Hall JE, Guyton AC, Smith MJ Jr, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol 239:F271-F280, 1980.
2. Osborn JL. Relation between sodium intake, renal function and the regulation of arterial pressure. Hypertension 17:I-91-I-96, 1991.
3. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286:F606-F616, 2004.
4. Romero JC, Rackelhoff JF. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34:943-949, 1999.
5. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160-166, 2002.
6. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation - contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923, 1996.
7. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signalling. Regul Peptides 91:21-27, 2000.
8. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37:547-553, 2001.
9. Majid DSA, LG Navar. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens 14:74S-82S, 2001.
10. Majid DS, Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39:293-297, 2002.
11. Majid DSA, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am J Physiol Regul Integ Comp Physiol 287:R27-R32, 2004.
12. Majid DSA, Navar LG. Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am J Physiol 262:F40-F46, 1992.
13. Wilcox CS, Deng X, Welch WJ. NO generation and action during changes in salt intake: roles of nNOS and macula densa. Am J Physiol 274:R1588-R1593, 1998.
14. Kitamoto S, Egashira K, Kataoka C, Usui M, Koyanagi M, Takemoto M, Takeshita A. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795-1800, 2000.
15. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 54:775-784, 1998.
16. 2-isoprostanes in salt-replete human hypertensives. Free Rad Biol Med 35:711-718, 2003.
17. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100:264-269, 1997.
18. Omoro SA, Majid DSA, El-Dahr SS, Navar LG. Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs. Am J Physiol Renal Physiol 276:F271-F277, 1999.
19. Majid DSA, Nishiyama A, Jackson KE, Castillo A. Superoxide scavenging attenuates renal responses to Angiotensin II during nitric oxide inhibition in anesthetized dogs. Am J Physiol Renal Physiol 288:F412-F419, 2005.
20. Samuni A, Winkelsberg D, Pinson A, Hahn SM, Mitchell JM, Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest 87:1526-1530, 1991.
21. Mitchell JM, Samuni A, Krisna MC, DeGraff WG, Ahn MS, Samuni U, Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29:2802-2807, 1990.
22. Nishiyama A, Seth DM, Navar LG. Angiotensin II type 1 receptormediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension. J Hypertens 21:1897-1903, 2003.
23. 2-isoprostanes as indicators of oxidant stress. Methods Mol Biol 186:57-66, 2002.
24. Roberts LJ II, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo (review). Free Radic Biol Med 15:28:505-513, 2000.
25. Omoro SA, Majid DSA, El-Dahr SS, Navar LG. Role of angiotensin II and bradykinin in the renal regional blood flow responses to ACE inhibition in sodium depleted dogs. Am J Physiol 79:F289-F293, 2002.
26. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 283:F957-F962, 2002.
27. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abey Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41:266-273, 2003.
28. Majid DSA, Said KE, Omoro SA, Navar LG. Nitric oxide dependency of arterial pressure-induced changes in renal interstitial hydrostatic pressure in dogs. Circ Res 88:347-351, 2001.
29. Wolin MS, Gupte SA, Lesaki T, Mohazzab-H KM. Oxidant and vascular nitric oxide signalling. In: Kadowitz PJ, McNamara DB, Eds. Nitric Oxide and the Regulation of the Peripheral Circulation. Boston: Birkhauser, pp33-48, 2000.
30. Jou SB, Cheng JT. The role of free radicals in the release of noradrenaline from myenteric nerve terminals of guinea-pig ileum. J Auton Nerv Syst 66:126-130, 1997.
31. Beckman JS, Crow JP. Patholological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21:330-334, 1993.
32. Mikkelson RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation induced signal transduction mechanisms. Oncogene 22:5734-5754, 2003.
33. Gow AJ, Farouh CR, Munson DA, Posencheg MA, Ischiropoulos H. Biological significance of nitric oxide mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 287:L262-L268, 2004.
34. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite induced membrane lipid peroxidation; the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:481-487, 1991.
35. Salgo MG, Stone K, Squadrito GL, Battista JR, Pryor WA. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem Biophys Res Commun 210:1025-1030, 1995.
36. Zhang J, Dawson VL, Dawson TM, Synder SH. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263:687-689, 1994.
37. Ischiropoulos H, Al-Mehdi AB. Peroxynitrite mediated oxidative protein modifications. FEBS Lett 364:279-282, 1995.
38. Liu S, Beckman JS, Ku DD. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther 268:1114-1121, 1994.
39. Nossaman BD, Dabisch PA, Liles JT, Baber SR, Champion HC, Kaye AD, Feng CJ, Anwar M, Bivalacqua TJ, Santiago JA, DeWitt BJ, Kadowitz PJ. Peroxynitrite does not impair pulmonary and systemic vascular responses. J Appl Physiol 96:455-462, 2004.
40. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, Lefer AM. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99:684-691, 1997.
41. Hou X, Roberts LJ II, Gobeil F Jr, Taber DF, Kanai K, Abran D, Brault S, Checchin D, Sennlaub F, Lachpelle P, Varma D, Chemtob S. Isomer specific contractile effects of a series of synthetic f2-isoprostane of retinal and cerebral microvasculature. Free Rad Biol Med 36:163-174, 2004.
42. Kityakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14:2775-2782, 2003.
43. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41:1346-1352, 2003.
44. Pech V, Sindhu RK, Vaziri ND, Majid DSA. Effects of chronic angiotensin II treatment on redox-enzyme proteins expression in the renal tissue in rats with varying salt intake. FASEB J 18:A282, 2004.
45. Rugale C, Delbose S, Cristol JP, Mimran A, Jover B. Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension. Am J Physiol Heart Circ Physiol 284:H1744-H1750, 2003.